D
Transgene SA
TRGNF
$0.70
-$0.89-55.98%
D
Sell
9/27/2024Upgraded
Transgene SA (TRGNF) was upgraded to D- from E+ on 9/27/2024 due to an increase in the valuation index and total return index.
Transgene SA (TRGNF) was upgraded to D- from E+ on 9/27/2024 due to an increase in the valuation index and total return index.
E
Sell
9/16/2024Downgrade
Transgene SA (TRGNF) was downgraded to E+ from D- on 9/16/2024 due to a decline in the volatility index.
Transgene SA (TRGNF) was downgraded to E+ from D- on 9/16/2024 due to a decline in the volatility index.
D
Sell
8/29/2024Upgraded
Transgene SA (TRGNF) was upgraded to D- from E+ on 8/29/2024 due to an increase in the volatility index.
Transgene SA (TRGNF) was upgraded to D- from E+ on 8/29/2024 due to an increase in the volatility index.
E
Sell
4/29/2024Downgrade
Transgene SA (TRGNF) was downgraded to E+ from D- on 4/29/2024 due to a decline in the valuation index and volatility index.
Transgene SA (TRGNF) was downgraded to E+ from D- on 4/29/2024 due to a decline in the valuation index and volatility index.
D
Sell
4/1/2024Upgraded
Transgene SA (TRGNF) was upgraded to D- from E+ on 4/1/2024 due to an increase in the volatility index.
Transgene SA (TRGNF) was upgraded to D- from E+ on 4/1/2024 due to an increase in the volatility index.
E
Sell
3/15/2024Downgrade
Transgene SA (TRGNF) was downgraded to E+ from D- on 3/15/2024 due to a decline in the growth index, solvency index and volatility index. Debt to equity increased from 0.59 to 0.6, earnings per share declined from -$0.0858 to -$0.0871, and operating cash flow declined 1.5% from -$9.47M to -$9.61M.
Transgene SA (TRGNF) was downgraded to E+ from D- on 3/15/2024 due to a decline in the growth index, solvency index and volatility index. Debt to equity increased from 0.59 to 0.6, earnings per share declined from -$0.0858 to -$0.0871, and operating cash flow declined 1.5% from -$9.47M to -$9.61M.
D
Sell
10/11/2023Upgraded
Transgene SA (TRGNF) was upgraded to D- from E+ on 10/11/2023 due to an increase in the valuation index and total return index.
Transgene SA (TRGNF) was upgraded to D- from E+ on 10/11/2023 due to an increase in the valuation index and total return index.
E
Sell
9/25/2023Downgrade
Transgene SA (TRGNF) was downgraded to E+ from D- on 9/25/2023 due to a decline in the valuation index.
Transgene SA (TRGNF) was downgraded to E+ from D- on 9/25/2023 due to a decline in the valuation index.
D
Sell
8/22/2023Upgraded
Transgene SA (TRGNF) was upgraded to D- from E+ on 8/22/2023 due to an increase in the total return index, valuation index and volatility index.
Transgene SA (TRGNF) was upgraded to D- from E+ on 8/22/2023 due to an increase in the total return index, valuation index and volatility index.
E
Sell
4/10/2023Downgrade
Transgene SA (TRGNF) was downgraded to E+ from D- on 4/10/2023 due to a significant decline in the growth index and valuation index. Earnings per share declined from -$0.0906 to -$0.0919, operating cash flow declined 1.4% from -$4.12M to -$4.18M, and EBIT declined 1.4% from -$7.65M to -$7.75M.
Transgene SA (TRGNF) was downgraded to E+ from D- on 4/10/2023 due to a significant decline in the growth index and valuation index. Earnings per share declined from -$0.0906 to -$0.0919, operating cash flow declined 1.4% from -$4.12M to -$4.18M, and EBIT declined 1.4% from -$7.65M to -$7.75M.
D
Sell
3/29/2023Upgraded
Transgene SA (TRGNF) was upgraded to D- from E+ on 3/29/2023 due to a noticeable increase in the total return index and volatility index.
Transgene SA (TRGNF) was upgraded to D- from E+ on 3/29/2023 due to a noticeable increase in the total return index and volatility index.
E
Sell
3/14/2023Downgrade
Transgene SA (TRGNF) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
Transgene SA (TRGNF) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/9/2023Upgraded
Transgene SA (TRGNF) was upgraded to D from E+ on 02/09/2023.
Transgene SA (TRGNF) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
Transgene SA (TRGNF) was downgraded to E+ from D on 2/8/2023 due to a substantial decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.27 to 0.28.
Transgene SA (TRGNF) was downgraded to E+ from D on 2/8/2023 due to a substantial decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.27 to 0.28.
D
Sell
8/30/2022Downgrade
Transgene SA (TRGNF) was downgraded to D from D+ on 8/30/2022 due to a noticeable decline in the volatility index and total return index.
Transgene SA (TRGNF) was downgraded to D from D+ on 8/30/2022 due to a noticeable decline in the volatility index and total return index.
D
Sell
6/16/2022Upgraded
Transgene SA (TRGNF) was upgraded to D+ from D on 6/16/2022 due to an increase in the volatility index and valuation index.
Transgene SA (TRGNF) was upgraded to D+ from D on 6/16/2022 due to an increase in the volatility index and valuation index.
D
Sell
5/31/2022Downgrade
Transgene SA (TRGNF) was downgraded to D from D+ on 5/31/2022 due to a decline in the volatility index.
Transgene SA (TRGNF) was downgraded to D from D+ on 5/31/2022 due to a decline in the volatility index.
D
Sell
5/16/2022Upgraded
Transgene SA (TRGNF) was upgraded to D+ from D- on 05/16/2022.
Transgene SA (TRGNF) was upgraded to D+ from D- on 05/16/2022.
D
Sell
5/13/2022Downgrade
Transgene SA (TRGNF) was downgraded to D- from D+ on 05/13/2022.
Transgene SA (TRGNF) was downgraded to D- from D+ on 05/13/2022.
D
Sell
5/5/2022Upgraded
Transgene SA (TRGNF) was upgraded to D+ from D- on 5/5/2022 due to an increase in the total return index.
Transgene SA (TRGNF) was upgraded to D+ from D- on 5/5/2022 due to an increase in the total return index.
D
Sell
5/1/2022Downgrade
Transgene SA (TRGNF) was downgraded to D- from D+ on 05/01/2022.
Transgene SA (TRGNF) was downgraded to D- from D+ on 05/01/2022.
D
Sell
4/21/2022Upgraded
Transgene SA (TRGNF) was upgraded to D+ from D- on 4/21/2022 due to an increase in the volatility index.
Transgene SA (TRGNF) was upgraded to D+ from D- on 4/21/2022 due to an increase in the volatility index.
D
Sell
4/20/2022Downgrade
Transgene SA (TRGNF) was downgraded to D- from D+ on 4/20/2022 due to a decline in the volatility index.
Transgene SA (TRGNF) was downgraded to D- from D+ on 4/20/2022 due to a decline in the volatility index.
D
Sell
4/18/2022Upgraded
Transgene SA (TRGNF) was upgraded to D+ from D on 4/18/2022 due to a substantial increase in the growth index, volatility index and solvency index. Earnings per share increased from -$0.0466 to -$0.0452, operating cash flow increased 2.94% from -$8.93M to -$8.67M, and EBIT increased 2.94% from -$6.05M to -$5.87M.
Transgene SA (TRGNF) was upgraded to D+ from D on 4/18/2022 due to a substantial increase in the growth index, volatility index and solvency index. Earnings per share increased from -$0.0466 to -$0.0452, operating cash flow increased 2.94% from -$8.93M to -$8.67M, and EBIT increased 2.94% from -$6.05M to -$5.87M.
D
Sell
11/23/2021Upgraded
Transgene SA (TRGNF) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
Transgene SA (TRGNF) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
D
Sell
11/8/2021Downgrade
Transgene SA (TRGNF) was downgraded to D- from D on 11/8/2021 due to a major decline in the growth index and volatility index. Earnings per share declined from -$0.0843 to -$0.0844, operating cash flow declined 0.04% from -$10.11M to -$10.11M, and EBIT declined 0.04% from -$8.09M to -$8.09M.
Transgene SA (TRGNF) was downgraded to D- from D on 11/8/2021 due to a major decline in the growth index and volatility index. Earnings per share declined from -$0.0843 to -$0.0844, operating cash flow declined 0.04% from -$10.11M to -$10.11M, and EBIT declined 0.04% from -$8.09M to -$8.09M.
D
Sell
9/8/2021Downgrade
Transgene SA (TRGNF) was downgraded to D from D+ on 9/8/2021 due to a decline in the valuation index.
Transgene SA (TRGNF) was downgraded to D from D+ on 9/8/2021 due to a decline in the valuation index.
D
Sell
7/30/2021Upgraded
Transgene SA (TRGNF) was upgraded to D+ from D on 7/30/2021 due to a substantial increase in the total return index, growth index and volatility index. Total revenue increased 1.93% from $2.41M to $2.45M.
Transgene SA (TRGNF) was upgraded to D+ from D on 7/30/2021 due to a substantial increase in the total return index, growth index and volatility index. Total revenue increased 1.93% from $2.41M to $2.45M.
D
Sell
7/8/2020Upgraded
Transgene SA (TRGNF) was upgraded to D from D- on 7/8/2020 due to an increase in the total return index and volatility index.
Transgene SA (TRGNF) was upgraded to D from D- on 7/8/2020 due to an increase in the total return index and volatility index.
D
Sell
6/23/2020Downgrade
Transgene SA (TRGNF) was downgraded to D- from D on 6/23/2020 due to a decline in the volatility index.
Transgene SA (TRGNF) was downgraded to D- from D on 6/23/2020 due to a decline in the volatility index.
D
Sell
6/4/2020Upgraded
Transgene SA (TRGNF) was upgraded to D from D- on 6/4/2020 due to an increase in the volatility index.
Transgene SA (TRGNF) was upgraded to D from D- on 6/4/2020 due to an increase in the volatility index.
D
Sell
5/14/2020Downgrade
Transgene SA (TRGNF) was downgraded to D- from D on 5/14/2020 due to a decline in the volatility index and total return index.
Transgene SA (TRGNF) was downgraded to D- from D on 5/14/2020 due to a decline in the volatility index and total return index.
D
Sell
4/29/2020Upgraded
Transgene SA (TRGNF) was upgraded to D from D- on 4/29/2020 due to an increase in the volatility index.
Transgene SA (TRGNF) was upgraded to D from D- on 4/29/2020 due to an increase in the volatility index.
D
Sell
4/13/2020Downgrade
Transgene SA (TRGNF) was downgraded to D- from D on 4/13/2020 due to a significant decline in the valuation index, efficiency index and growth index. Total revenue declined 0.44% from $4.84M to $4.82M.
Transgene SA (TRGNF) was downgraded to D- from D on 4/13/2020 due to a significant decline in the valuation index, efficiency index and growth index. Total revenue declined 0.44% from $4.84M to $4.82M.
D
Sell
8/5/2019Downgrade
Transgene SA (TRGNF) was downgraded to D from D+ on 8/5/2019 due to a noticeable decline in the total return index and volatility index.
Transgene SA (TRGNF) was downgraded to D from D+ on 8/5/2019 due to a noticeable decline in the total return index and volatility index.
D
Sell
6/18/2019Downgrade
Transgene SA (TRGNF) was downgraded to D+ from C- on 6/18/2019 due to a decline in the volatility index.
Transgene SA (TRGNF) was downgraded to D+ from C- on 6/18/2019 due to a decline in the volatility index.
C
Hold
5/21/2019Upgraded
Transgene SA (TRGNF) was upgraded to C- from D+ on 5/21/2019 due to an increase in the volatility index, total return index and valuation index.
Transgene SA (TRGNF) was upgraded to C- from D+ on 5/21/2019 due to an increase in the volatility index, total return index and valuation index.
D
Sell
4/23/2019Upgraded
Transgene SA (TRGNF) was upgraded to D+ from D on 4/23/2019 due to a significant increase in the valuation index, efficiency index and volatility index.
Transgene SA (TRGNF) was upgraded to D+ from D on 4/23/2019 due to a significant increase in the valuation index, efficiency index and volatility index.
D
Sell
5/10/2017Upgraded
Transgene SA (TRGNF) was upgraded to D from D- on 5/10/2017 due to a noticeable increase in the growth index, solvency index and efficiency index. Operating cash flow increased 3.57% from -$10.55M to -$10.18M, EBIT increased 3.57% from -$6.42M to -$6.19M, and net income increased 3.57% from -$7.31M to -$7.05M.
Transgene SA (TRGNF) was upgraded to D from D- on 5/10/2017 due to a noticeable increase in the growth index, solvency index and efficiency index. Operating cash flow increased 3.57% from -$10.55M to -$10.18M, EBIT increased 3.57% from -$6.42M to -$6.19M, and net income increased 3.57% from -$7.31M to -$7.05M.
D
Sell
3/11/2016Downgrade
Transgene SA (TRGNF) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and solvency index.
Transgene SA (TRGNF) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and solvency index.
D
Sell
6/26/2015Downgrade
Transgene SA (TRGNF) was downgraded to D from D+ on 6/26/2015 due to a large decline in the volatility index, total return index and efficiency index. Net income declined 5.71% from -$15.53M to -$14.64M, and total capital declined 4.09% from $156.53M to $150.13M.
Transgene SA (TRGNF) was downgraded to D from D+ on 6/26/2015 due to a large decline in the volatility index, total return index and efficiency index. Net income declined 5.71% from -$15.53M to -$14.64M, and total capital declined 4.09% from $156.53M to $150.13M.
D
Sell
6/20/2014None
Transgene SA (TRGNF) was downgraded to D+ from U on 06/20/2014.
Transgene SA (TRGNF) was downgraded to D+ from U on 06/20/2014.
OTC PK
04/01/2025 1:07PM Eastern
Quotes delayed
